Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbohydrate polymers, also known as polysaccharides, are complex biomolecules consisting of long chains of monosaccharide units joined by glycosidic bonds (Wikipedia, 2023). They play critical roles in biological systems, serving as primary energy reserves, such as starch and glycogen, and essential structural components, such as cellulose in plants and chitin in fungi (NCBI, 2022). In a pharmacological context, specific carbohydrate polymers are often targeted or utilized; for instance, bacterial peptidoglycan and fungal beta-glucans are key targets for antimicrobial drugs like beta-lactams and echinocandins (PubMed, 2021). Furthermore, glycosaminoglycans like heparin and hyaluronic acid are vital in human physiology for anticoagulation and joint lubrication, respectively (StatPearls, 2023). Because the term encompasses a vast array of chemically distinct molecules, it is generally considered a broad molecular class rather than a single, specific therapeutic target (PubChem, 2024).
Inhibition of biosynthesis (e.g., cell wall synthesis), enzymatic degradation, or competitive binding to protein partners.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbohydrate polymer.